|
1.
|
RS VasanMG LarsonEP LeipWB KannelD
LevyAssessment of frequency of progression to hypertension in
non-hypertensive participants in the Framingham Heart Study: a
cohort
studyLancet35816821686200110.1016/S0140-6736(01)06710-111728544
|
|
2.
|
J HsiaKL MargolisCB EatonPrehypertension
and cardiovascular disease risk in the Women’s Health
InitiativeCirculation1158558602007
|
|
3.
|
S KnechtH WerschingH LohmannHigh-normal
blood pressure is associated with poor cognitive
performanceHypertension51663668200810.1161/HYPERTENSIONAHA.107.10557718250360
|
|
4.
|
DR MullicanC LorenzoSM HaffnerIs
prehypertension a risk factor for the development of type 2
diabetes?Diabetes Care3218701872200910.2337/dc09-032819628813
|
|
5.
|
T NinomiyaM KuboY DoiPrehypertension
increases the risk for renal arteriosclerosis in autopsies: the
Hisayama StudyJ Am Soc
Nephrol1821352142200710.1681/ASN.200701006717582160
|
|
6.
|
AV ChobanianGL BakrisHR BlackThe Seventh
Report of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure: the JNC 7
reportJAMA28925602572200310.1001/jama.289.19.2560
|
|
7.
|
S JuliusSD NesbittBM EganFeasibility of
treating prehypertension with an angiotensin-receptor blockerN Engl
J Med35416851697200610.1056/NEJMoa06083816537662
|
|
8.
|
S LudersJ SchraderJ BergerThe PHARAO
study: prevention of hypertension with the angiotensin-converting
enzyme inhibitor ramipril in patients with high-normal blood
pressure: a prospective, randomized, controlled prevention trial of
the German Hypertension LeagueJ
Hypertens2614871496200810.1097/HJH.0b013e3282ff8864
|
|
9.
|
SB HarrapWM Van der MerweSA GriffinF
MacphersonAF LeverBrief angiotensin converting enzyme inhibitor
treatment in young spontaneously hypertensive rats reduces blood
pressure
long-termHypertension16603614199010.1161/01.HYP.16.6.603
|
|
10.
|
M BaumannBJ JanssenJJ HermansTransient AT1
receptor-inhibition in prehypertensive spontaneously hypertensive
rats results in maintained cardiac protection until advanced ageJ
Hypertens25207215200710.1097/HJH.0b013e3280102bff
|
|
11.
|
M BaumannJJ HermansBJ JanssenTransient
prehypertensive treatment in spontaneously hypertensive rats: a
comparison of spironolactone and losartan regarding long-term blood
pressure and target organ damageJ
Hypertens2525042511200710.1097/HJH.0b013e3282ef84f8
|
|
12.
|
D TomassoniM SabbatiniF AmentaEffect of
different dihydropyridine-type Ca2+ antagonists on left
ventricle hypertrophy and coronary changes in spontaneously
hypertensive ratsJ Cardiovasc Pharmacol41544552200312658055
|
|
13.
|
M WatanabeH KawaguchiH OnozukaChronic
effects of enalapril and amlodipine on cardiac remodeling in
cardiomyopathic hamster heartsJ Cardiovasc
Pharmacol32248259199810.1097/00005344-199808000-000129700987
|
|
14.
|
RE WiddopXC LiA simple versatile method
for measuring tail cuff systolic blood pressure in conscious
ratsClin Sci (Lond)9319119419979337632
|
|
15.
|
RM LangM BierigRB DevereuxRecommendations
for chamber quantification: a report from the American Society of
Echocardiography’s Guidelines and Standards Committee and the
Chamber Quantification Writing Group, developed in conjunction with
the European Association of Echocardiography, a branch of the
European Society of CardiologyJ Am Soc
Echocardiogr1814401463200516376782
|
|
16.
|
J FloegeB HackmannV KliemAge-related
glomerulosclerosis and interstitial fibrosis in Milan normotensive
rats: a podocyte diseaseKidney
Int51230243199710.1038/ki.1997.288995738
|
|
17.
|
Y XuD KumarJR DyckAT(1) and AT(2) receptor
expression and blockade after acute ischemia-reperfusion in
isolated working rat heartsAm J Physiol Heart Circ
Physiol282H1206H1215200210.1152/ajpheart.00839.200011893553
|
|
18.
|
KL ChristensenLT JespersenMJ
MulvanyDevelopment of blood pressure in spontaneously hypertensive
rats after withdrawal of long-term treatment related to vascular
structureJ
Hypertens78390198910.1097/00004872-198902000-000022522478
|
|
19.
|
K IshiguroH SasamuraY SakamakiH ItohT
SarutaDevelopmental activity of the renin-angiotensin system during
the ‘critical period’ modulates later L-NAME-induced hypertension
and renal injuryHypertens Res3063752007
|
|
20.
|
H NakayaH SasamuraM MifunePrepubertal
treatment with angiotensin receptor blocker causes partial
attenuation of hypertension and renal damage in adult Dahl
salt-sensitive ratsNephron91710718200210.1159/00006503512138277
|
|
21.
|
H SasamuraK HayashiK IshiguroH NakayaT
SarutaH ItohPrevention and regression of hypertension: role of
renal microvascular protectionHypertens
Res32658664200910.1038/hr.2009.8519521419
|
|
22.
|
AK KeatonCR WhiteKH BerecekCaptopril
treatment and its withdrawal prevents impairment of
endothelium-dependent responses in the spontaneously hypertensive
ratClin Exp
Hypertens20847866199810.3109/106419698090532519817606
|
|
23.
|
L ZhangDG EdwardsKH BerecekEffects of
early captopril treatment and its removal on plasma angiotensin
converting enzyme (ACE) activity and arginine vasopressin in
hypertensive rats (SHR) and normotensive rats (WKY)Clin Exp
Hypertens18201226199610.3109/106419696090817658869001
|
|
24.
|
JN WuKH BerecekPrevention of genetic
hypertension by early treatment of spontaneously hypertensive rats
with the angiotensin converting enzyme inhibitor
captoprilHypertension22139146199310.1161/01.HYP.22.2.1398340149
|
|
25.
|
M BaumannBJ JanssenJJ Rob HermansR
BartholomeJF SmitsHA Struijker BoudierRenal medullary effects of
transient prehypertensive treatment in young spontaneously
hypertensive ratsActa Physiol
(Oxf)196231237200910.1111/j.1748-1716.2008.01916.x18983459
|
|
26.
|
MA SevillaF VocesR CarronAmlodipine
decreases fibrosis and cardiac hypertrophy in spontaneously
hypertensive rats: persistent effects after withdrawalLife
Sci75881891200410.1016/j.lfs.2004.04.00415183079
|
|
27.
|
K TakemoriH IshidaH ItoContinuous
inhibition of the renin-angiotensin system and protection from
hypertensive end-organ damage by brief treatment with angiotensin
II type 1 receptor blocker in stroke-prone spontaneously
hypertensive ratsLife
Sci7722332245200510.1016/j.lfs.2004.12.048
|
|
28.
|
M BaderRole of the local renin-angiotensin
system in cardiac damage: a minireview focussing on transgenic
animal modelsJ Mol Cell
Cardiol3414551462200210.1006/jmcc.2002.207712431444
|
|
29.
|
K MizunoM TaniS HashimotoEffects of
losartan, a nonpeptide angiotensin II receptor antagonist, on
cardiac hypertrophy and the tissue angiotensin II content in
spontaneously hypertensive ratsLife
Sci51367374199210.1016/0024-3205(92)90589-H
|
|
30.
|
MA AdamsA BobikPI KornerDifferential
development of vascular and cardiac hypertrophy in genetic
hypertension. Relation to sympathetic
functionHypertension14191202198910.1161/01.HYP.14.2.1912527201
|
|
31.
|
R BurgesD MoiseyUnique pharmacologic
properties of amlodipineAm J
Cardiol732A9A199410.1016/0002-9149(94)90268-2
|
|
32.
|
T NaitoLJ MaH YangAngiotensin type 2
receptor actions contribute to angiotensin type 1 receptor blocker
effects on kidney fibrosisAm J Physiol Renal
Physiol298F683F691201010.1152/ajprenal.00503.200920042458
|
|
33.
|
K SkovH EiskjaerHE HansenJK MadsenS
KvistMJ MulvanyTreatment of young subjects at high familial risk of
future hypertension with an angiotensin-receptor
blockerHypertension508995200710.1161/HYPERTENSIONAHA.107.08953217485597
|
